These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Glioma proliferation as assessed by 3'-fluoro-3'-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma. Ullrich R; Backes H; Li H; Kracht L; Miletic H; Kesper K; Neumaier B; Heiss WD; Wienhard K; Jacobs AH Clin Cancer Res; 2008 Apr; 14(7):2049-55. PubMed ID: 18381944 [TBL] [Abstract][Full Text] [Related]
6. Comparison of 3'-deoxy-3'-[18F]fluorothymidine PET and O-(2-[18F]fluoroethyl)-L-tyrosine PET in patients with newly diagnosed glioma. Jeong SY; Lim SM Nucl Med Biol; 2012 Oct; 39(7):977-81. PubMed ID: 22483845 [TBL] [Abstract][Full Text] [Related]
7. Diagnostic value of PET/CT with Ogawa T; Kawai N; Miyake K; Shinomiya A; Yamamoto Y; Nishiyama Y; Tamiya T EJNMMI Res; 2020 May; 10(1):44. PubMed ID: 32382870 [TBL] [Abstract][Full Text] [Related]
8. Correlation of 18F-FLT uptake with tumor grade and Ki-67 immunohistochemistry in patients with newly diagnosed and recurrent gliomas. Yamamoto Y; Ono Y; Aga F; Kawai N; Kudomi N; Nishiyama Y J Nucl Med; 2012 Dec; 53(12):1911-5. PubMed ID: 23081994 [TBL] [Abstract][Full Text] [Related]
12. Evaluation of 3'-deoxy-3'-[18F]-fluorothymidine (18F-FLT) kinetics correlated with thymidine kinase-1 expression and cell proliferation in newly diagnosed gliomas. Shinomiya A; Kawai N; Okada M; Miyake K; Nakamura T; Kushida Y; Haba R; Kudomi N; Yamamoto Y; Tokuda M; Tamiya T Eur J Nucl Med Mol Imaging; 2013 Jan; 40(2):175-85. PubMed ID: 23229746 [TBL] [Abstract][Full Text] [Related]
13. Imaging regional variation of cellular proliferation in gliomas using 3'-deoxy-3'-[18F]fluorothymidine positron-emission tomography: an image-guided biopsy study. Price SJ; Fryer TD; Cleij MC; Dean AF; Joseph J; Salvador R; Wang DD; Hutchinson PJ; Clark JC; Burnet NG; Pickard JD; Aigbirhio FI; Gillard JH Clin Radiol; 2009 Jan; 64(1):52-63. PubMed ID: 19070698 [TBL] [Abstract][Full Text] [Related]
14. 18F-FLT PET performs better than 18F-FDG PET in differentiating malignant uterine corpus tumors from benign leiomyoma. Yamane T; Takaoka A; Kita M; Imai Y; Senda M Ann Nucl Med; 2012 Jul; 26(6):478-84. PubMed ID: 22477262 [TBL] [Abstract][Full Text] [Related]
15. Comparison of 4'-[methyl-(11)C]thiothymidine ((11)C-4DST) and 3'-deoxy-3'-[(18)F]fluorothymidine ((18)F-FLT) PET/CT in human brain glioma imaging. Toyota Y; Miyake K; Kawai N; Hatakeyama T; Yamamoto Y; Toyohara J; Nishiyama Y; Tamiya T EJNMMI Res; 2015; 5():7. PubMed ID: 25853013 [TBL] [Abstract][Full Text] [Related]
16. Metabolic assessment of gliomas using 11C-methionine, [18F] fluorodeoxyglucose, and 11C-choline positron-emission tomography. Kato T; Shinoda J; Nakayama N; Miwa K; Okumura A; Yano H; Yoshimura S; Maruyama T; Muragaki Y; Iwama T AJNR Am J Neuroradiol; 2008 Jun; 29(6):1176-82. PubMed ID: 18388218 [TBL] [Abstract][Full Text] [Related]